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 Abstract  Immune aging results in a decreased competence of adaptive immunity 
with an increased risk for autoimmunity. However, the mechanistic links between 
the immune aging and autoimmunity remain elusive. We reported that a PD-1 + 
memory phenotype (MP) CD4 + T cell population is increased as normal mice age, 
termed senescence-associated (SA-) T cells. The SA-T cells show characteristic 
signs and features of cellular senescence and emerge as follicular T cells in sponta-
neous germinal centers (GCs) that occur in aged mice. Spontaneous development of 
GCs is a hallmark of systemic autoimmune diseases, and we found that the develop-
ment of SA-T cells is robustly and prematurely accelerated in bona ﬁ de lupus-prone 
mice in association with spontaneous, auto-reactive GCs. A fraction of the SA-T 
cells deﬁ ned by CD153 expression is activated by autologous GC B cells to produce 
a plethora of inﬂ ammatory factors in a TCR-dependent manner and contributes to 
the expansion of the GC reactions, although the remaining part of them is rendered 
TCR anergic in situ. The results uncover that accelerated T cell senescence under-
lies the development of autoimmunity in systemic lupus erythematosus. 
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 Introduction: Immune Aging and Senescence-
Associated T Cells 
 Immune aging (immunosenescence) is characterized by the reduced competence of 
acquired immunity, leading to increased susceptibility to infection as well as 
decreased vaccination efﬁ ciency. Recent accumulating evidence indicates that 
immunosenescence underlies an increased proinﬂ ammatory trait with age, 
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including various chronic inﬂ ammatory and metabolic disorders, such as athero-
sclerosis and diabetes mellitus, as well as an increased risk for autoimmunity [ 1 ]. 
Cellular senescence is characterized by irreversible arrest of proliferation, grossly 
altered gene expression, and relative resistance to apoptosis [ 2 ]. Notably, senescent 
cells are often metabolically active and may become foci of host reactions in tissues 
by secreting various inﬂ ammatory factors [ 3 ]. The features and consequences of 
 cellular senescence in T cells in the immune system, however, remain elusive. 
 One of the most prominent changes occurring in the immune organs with age is 
an early involution of the thymus. The thymus is a central immune organ to support 
T cell development and establish T cell self-tolerance. The T cell generation in the 
thymus is most active at the late embryonic through neonatal stages, but the activity 
sharply declines after the juvenile stage, eventually replaced almost entirely by fat 
tissues at later stages of life (Fig.  1a ). Although the mechanism of early thymic 
involution remains elusive, it is suggested that the rapid decrease of thymic  epithelial 
stem cell (TECSC) activity after birth nay play a crucial role in it [ 4 ]. In  concordance 
 Fig. 1  (a) The thymus shows early involution with age.  (b) The proportions of SA-T cells in 




with the decrease of neo-T cell genesis, the peripheral naïve T cells are gradually 
reduced with age. Although the peripheral T cell pool is well maintained in aged 
individuals, the population shows a steady increase in the proportions of memory 
phenotype (MP) T cells [ 5 ]. It is suggested that these MP T cells include those that 
have homeostatically expanded in response to the decreasing drift of the T cell 
 numbers, in addition to the authentic memory T cells for speciﬁ c environmental 
antigens [ 5 ]. We reported that a unique PD-1 + MP CD4 + T cell population is 
increased with age [ 6 ], now termed senescence-associated (SA-) T cells (Fig.  1b ). 
The SA-T cells showed compromised capacity of clonal proliferation and produc-
tion of typical T cell–speciﬁ c cytokines via TCR-stimulation; however, the SA-T 
cells secrete abundant proinﬂ ammatory cytokines such as osteopontin (OPN) [ 6 ].
 SA-T Cells Represent an Endogenously Arising Follicular T 
Cell Population with Age 
 We found that normal aged mice often developed GCs spontaneously in the 
 secondary lymphoid tissues, and the SA-T cells were detected mostly in the GCs, 
representing follicular T cells (Fig.  2 ). In agreement with the follicular localization, 
the majority of SA-T cells expressed ICOS and CD200, similarly to the typical 
 follicular helper T cells induced by immunization with exogenous antigens such as 
sheep red blood cells (SRBC-TFH). However, a signiﬁ cant portion of the SA-T 
cells additionally expressed CD153 (CD30L), which was rarely expressed in SRBC-
TFH cells. Functionally, CD153 + SA-T cells showed compromised proliferation but 
produced large amounts of OPN via TCR-stimulation with much less IL-4 and 
 Fig. 2  Spontaneous development of germinal centers (GCs) in the secondary lymphoid tissues of 
normal aged nice, containing abundant PD-1 + follicular T cells 
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IFN-γ, whereas the rest of the CD153 − population did not proliferate or produce any 
of these cytokines at all, suggesting that these cells were TCR unresponsive. The 
SA-T cells showed a unique transcriptome (Fig.  3 ) different from those of PD-1 MP 
CD4 + T cells and SRBC-TFH cells, but the CD153 + and CD153 − fractions of the 
SA-T cells had very similar transcriptome proﬁ les to each other, despite the distinct 
TCR responsiveness. The results suggest that SA-T cells represent a unique type of 
follicular CD4 + T cell population, a fraction of which is rendered TCR anergic in 
situ. Although CD153 + and CD153 − SA-T cells became detectable only in normal 
aged mice, the development was remarkably accelerated in the adult- thymectomized 
mice or γ-ray irradiated with transplanted naïve T cells. The results strongly suggest 
that the SA-T cells are generated in the process of homeostatic T cell  proliferation, 
either acutely or chronically depending on the extent and tempo of the decrease in a 
peripheral T cell pool.
 SA-T Cells Increase Robustly in Bone Fide Lupus-Prone Mice 
 Spontaneous GC reactions are a hallmark of systemic autoimmune diseases, 
 including lupus [ 7 ,  8 ], and the ﬁ ndings above prompted us to examine them in 
female BWF1 mice, a bona ﬁ de mouse model of human SLE. Female BWF1 mice 
robustly developed GCs with a remarkable increase of follicular PD-1 + MP CD4 + T 
cells beginning from as early as 6 months of age (Fig.  4a ); this was not the case in 
male BWF1 mice or parental NZW mice. A signiﬁ cant portion of them expressed 
CD153 in addition to other follicular T cell markers such as CXCR5, ICOS, and 
Bcl-6 (Fig.  4b ). Transcriptome analysis conﬁ rmed that both CD153 + and CD153 − 
cell fractions showed highly coincidental proﬁ les with the corresponding SA-T 




cells in normal aged mice, rather than SRBC-TFH cells. Moreover, the TCR- 
stimulated CD153 + cell fraction produced abundant OPN in addition to other 
inﬂ ammatory chemokines (Ccl1, Ccl3, Ccl4) with minimal production of T cell–
speciﬁ c cytokines, whereas the CD153 − fraction produced no cytokines at all, 
including OPN. Overall, the follicular T cells in female BWF1 mice showed  features 
essentially identical to those of the SA-T cells in normal aged mice, except for more 
robust and earlier development.
 SA-T Cells Show Typical Signs and Features of Cellular 
Senescence 
 Transcriptome proﬁ les of the SA-T cells of both aged B6 and female BWF1 mice 
revealed the up-regulation of a numbers of genes coding for potentially inﬂ amma-
tory factors including  Spp1 (Fig.  5a ). The feature was reminiscent of a so-called 
senescence-associated secretory phenotype (SASP) [ 3 ], and indeed the expression 
of  Cebpb , shown to be involved in the regulation of SASP, was also increased. In 
addition, the SA-T cells revealed increased expression of  Cdkn1a (Cip1) and 
 Cdkn2b (Ink4b) (Fig.  5b ), which are representative senescence-associated biomark-
ers [ 9 ,  10 ], remarkably increased nuclear heterochromatin foci, and higher SA-β-
Gal activity than PD-1 − CD4 + T cells (Fig.  5c ). Also, the SA-T cells were highly 
stable in culture and survived for long terms without proliferation. All of these 
results are consistent with the notion that the SA-T cells represent the T cells in cel-
lular senescence.
 Fig. 4  Lupus-prone female BWF1 mice robustly and spontaneously develop GCs containing 
abundant SA-T cells much earlier than normal mice 
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 Fig. 5  SA-T cells reveal the signs and features of cellular senescence, including a senescence- 
associated secretory phenotype (SASP), senescence biomarkers (Cdkn1a, Cdkn2b), increased 




 SA-T Cells Are Activated in Response to Autologous GC B 
Cells to Produce OPN that Protects Against B Cell Apoptosis 
in GCs 
 The  Spp1 transcripts were sharply increased in the spleens of female BWF1 mice 
from around 5 months of age, in concordance with the overt GC reactions. Analysis 
with laser-capture microdissection (LMD) revealed that the  Spp1 was conﬁ ned to 
the PNA + GC regions, whereas the GCs in SRBC-immunized B6 mice hardly 
expressed  Spp1 . When SA-T cells from female BWF1 mice were co-cultured with 
γ-ray-irradiated autologous B cells, the CD153 + , but hardly TCR-anergic CD153 − , 
fraction produced signiﬁ cant amounts of OPN. The response was induced by CD95 + 
GC B cells more efﬁ ciently than CD95 − B cells and was inhibited signiﬁ cantly in 
the presence of anti-MHC II or soluble anti-CD3 antibody, suggesting that the SA-T 
cells recognized self-antigens presented by GC B cells via TCR. Curiously,  however, 
the response was unaffected in the presence of anti-PD-L2 antibody, albeit that the 
GC-B cells expressed PD-L2, suggesting that the OPN production by CD153 + SA-T 
cells is mediated by a PD-1-resistant, alternative TCR-signaling pathway (Fig.  6 ). 
On the other hand, the OPN production in response to GC-B cells was signiﬁ cantly 
enhanced by CD30-Ig agonistic to CD153 (Fig.  6 ). The primary B cells from female 
BWF1 mice showed signiﬁ cant cell death from stimulation with anti-μ antibody. 
However, OPN prevented B cell death and accordingly enhanced the secretion of 
anti-dsDNA antibody in vitro. Upon analysis using a WEHI231 B1 cell line, it was 
indicated that OPN inhibited the BCR-induced apoptosis by inducing the  expression 
of  Bcl2a1a, which is known to be crucial for B cell survival (Fig.  6 ). The results 
suggest that the SA-T cells speciﬁ cally recognize GC-B cells and locally produce 
OPN, which in turn protects the GC B cells from antigen-induced apoptosis.
 Involvement of SA-T Cells in the Expansion of GCs 
and Autoimmunity in Lupus 
 To directly investigate the role of SA-T cells in GC reaction, we isolated PD-1 − MP 
CD4 + and SA-T cells from female BWF1 mice with overt lupus disease and 
 transferred them into pre-disease young BWF1 mice. We found that the CD153 + 
SA-T cells caused a signiﬁ cant increase in GC sizes in the recipients, whereas the 
PD-1 − MP CD4 + cells barely affected the GC reactions. Moreover, a partial  depletion 
of CD153 + SA-T cells in female BWF1 mice at 4 months of age by treatment with 
a rat anti-CD153 antibody (500 μg/head) twice a week for 4 weeks resulted in 
 signiﬁ cant reduction of GC sizes as well as BC-B cells; none of these mice devel-
oped signiﬁ cant anti-dsDNA antibody, whereas 20 % (3 out of 15) of control mice 
showed a burst of anti-dsDNA antibody. These results suggest that CD153 + SA-T 
cells are directly involved in the growth of spontaneous GCs and autoantibody 
 production in female BWF1 mice. 
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 Conclusion and Perspectives 
 Among a number of changes in immune function with age is an increasing risk for 
autoimmunity [ 1 ]. We previously proposed that the increase of SA-T cells chroni-
cally with age and acutely with a leukemic condition might be related to the decrease 
of T cell genesis due to physiological thymic involution and leukemia-associated 
T-lymphocytopenia, respectively [ 6 ]. In a lymphopenic condition, the peripheral 
CD4 + T cells undergo homeostatic proliferation, which depends on homeostatic 
cytokines and tonic TCR-signal via MHC II–bearing self-peptides [ 5 ]. As such, the 
sustained CD4 + T cell homeostatic proliferation may lead to an increased risk for 
autoimmunity [ 11 ]. It was reported that CD4 + T cell homeostatic proliferation 
 Fig. 6  CD153 + SA-T cells speciﬁ cally respond to own GC-B cells and produce abundant OPN, 
which prevent the B cells from BCR-induced apoptosis. The TCR-signaling pathway is enhanced 
via CD153 co-stimulatory activity but is unaffected by negative PD-1 signaling. The CD153 + 
SA-T cells may eventually be rendered TCR anergic via a tolerance checkpoint and become 




underlies the development of autoimmune diabetes in female NOD mice [ 12 ]. 
Lymphopenia is one of the characteristic features in lupus disease, and therefore we 
propose that CD4 + T cell homeostatic proliferation underlies the robust and 
 premature development of SA-T cells. A recent report suggests that homeostatically 
proliferating PD-1 + CD4 + T cells may show different energy metabolism from CD4 + 
T cells driven by antigens in immune response [ 13 ]. Homeostatic proliferation is not 
associated with the transition to the effector phase as in immune response, and the 
possibility that the persistence of such a proliferative state with particular energy 
metabolism leads to a higher propensity for the progression of cellular senescence 
would be intriguing (Fig.  7 ). In conclusion, our current results indicate that SA-T 
cells play an important part in lupus pathogenesis and may provide a novel 
 therapeutic clue for controlling human SLE.
 Fig. 7  Normal naïve CD4 + T cells are activated in response to the speciﬁ c foreign antigens 
 presented by professional antigen-presenting cells (APCs), such as DCs, and show a robust clonal 
expansion, followed by maturation to the effector cells or quiescent memory cells. In lymphopenic 
conditions, however, naïve CD4 + T cells proliferate polyclonally, called homeostatic proliferation, 
which depends on the APCs such as B cells presenting self-peptides and homeostatic cytokines, to 
maintain the peripheral T cell pool. The sustained homeostatic proliferation may result in an 
increased risk for autoimmunity as well as T cell senescence to become SA-T cells. The (CD153 + ) 
SA-T cells are quite stable and metabolically active, producing abundant inﬂ ammatory factors 
such as OPN and chemokines, and become inﬂ ammatory foci in tissues. In the lupus-prone genetic 
background such as BWF1 with a defective B cell self-tolerance checkpoint, the SA-T cells are 
involved in auto-reactive GC reactions and promote overt autoantibody production 
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